LCI Industries Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LCI Industries - LCIIBusiness Wire · 4 days ago
LCI Industries Third Quarter 2026 Conference Call Scheduled for November 5, 2026, at 8:30 a.m. ETBusiness Wire · 4 days ago
LCI Industries Q2 Earnings Call HighlightsMarketBeat · Aug 8, 2026
LCI Industries Declares Quarterly Cash DividendBusiness Wire · Aug 7, 2026Lannett Company, Inc. operates as a U.S.-based pharmaceutical firm dedicated to the comprehensive process of developing, manufacturing, packaging, commercializing, and distributing generic versions of established brand-name drugs. Its extensive product portfolio encompasses a wide array of dosage forms, including solid oral, extended-release, topical, liquid, nasal, ophthalmic, injectable, patch, foam, buccal, sublingual, and suspension preparations. These generic medications address a broad spectrum of therapeutic areas, such as cardiovascular health, central nervous system disorders, endocrinology, gastrointestinal issues, infectious diseases, pain management, respiratory conditions, and mental health.